3 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
Follow Multihance: new trials by email Literature Review of Multihance trials Research Report on Multihance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol - Prostate Carcinoma | Phase 2 | Withdrawn | Northwestern University | 2023-06-17 | 2025-10-21 | |
| Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS (18F)FES, Gadobenate dimeglumine - Breast Cancer, Ductal Carcinoma in Situ - Category | Phase 2 | Completed | University of Wisconsin, Madison | 12 | 2019-01-03 | 2025-02-12 |
| P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) P03277, Gadobenate dimeglumine, MRI - CNS Lesion, Blood Brain Barrier Defect | Phase 2 | Completed | Guerbet | 312 | 2016-06-01 | 2021-10-25 |
| Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients Regadenoson MRI, Gadobenate dimeglumine - Atrial Fibrillation, Coronary Artery Disease | Phase 2 | Completed | University of Utah | 30 | 2013-01-01 | 2017-12-13 |
Atrial Fibrillation (1) · Breast Neoplasms (1) · Coronary Artery Disease (1) · Prostatic Neoplasms (1)
Guerbet (1) · Northwestern University (1) · University of Utah (1) · University of Wisconsin, Madison (1)
United States (4) · Belgium (1) · Czechia (1) · Hungary (1) · Italy (1) · Mexico (1) · Poland (1) · South Korea (1)
Amy Fowler (1) · Brent Wilson, MD (1) · Edward M Schaeffer, MD/PhD (1)
KL2TR000428 (1), P30CA014520 (1), P30CA060553 (1)